Answers are grounded in this paper and cite their sources.
Background Wearable bioimpedance technology offers a potentially accessible method for assessing total body water (TBW), yet its agreement with laboratory-based approaches in adults with Down syndrome remains unclear. The purpose of this study was to evaluate whether a wearable bioimpedance device demonstrates agreement with laboratory-based bioelectrical impedance spectroscopy (BIS) estimates of TBW comparable to standing bioimpedance devices in adults with Down syndrome. Methods Sixteen adults with Down syndrome (age: 28.3 ± 9.2 year; height: 150.9 ± 7.8 cm; body mass: 77.4 ± 20.3 kg) completed TBW assessment using BIS (reference), a wearable bioimpedance device (BIA W ), and two standing multi-frequency bioimpedance analyzers (BIA ST1 , BIA ST2 ). Results Repeated measures ANOVA revealed significant differences among devices (F (3,42) = 17.52, p < 0.001). Both standing devices produced lower TBW values compared with BIS (p < 0.001; d = 1.32 and 1.00), whereas BIA W did not differ from BIS (p = 0.106; d = 0.45). All devices demonstrated strong correlations with BIS (r = 0.92–0.93). Bland–Altman analyses showed systematic underestimation for standing devices (− 3.12 ± 4.65 L and − 2.36 ± 4.64 L), while the wearable exhibited the smallest bias (− 1.07 ± 4.64 L). Standard error of estimate values were similar across devices (2.34–2.45 L). Conclusion These findings indicate that wearable bioimpedance technology demonstrated closer agreement with laboratory-based TBW estimates than standing devices.
No takes yet. Share an insight, caveat, or question.
Esco et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: